{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:10:30Z","timestamp":1781284230744,"version":"3.54.1"},"reference-count":35,"publisher":"China Science Publishing & Media Ltd.","issue":"6","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.3724\/abbs.2024181","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:27:57Z","timestamp":1739399277000},"page":"916-926","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["MiR-133b-3p attenuates angiotensin II-induced cardiac hypertrophy through the inhibition of apoptosis by targeting <italic>CDIP1<\/italic>"],"prefix":"10.3724","volume":"57","author":[{"given":"Jiwei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"Nakamura M","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol, 2018, 15: 387-407.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41569-022-00756-z","volume":"20","author":"Kamel R","year":"2023","unstructured":"Kamel R, Leroy J, Vandecasteele G, Fischmeister R. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure. Nat Rev Cardiol, 2023, 20: 90-108.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","volume":"20","author":"Martin TG","year":"2023","unstructured":"Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol, 2023, 20: 347-363.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","volume":"63","author":"Yildiz M","year":"2020","unstructured":"Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis, 2020, 63: 10-21.","journal-title":"Prog Cardiovasc Dis"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/cvr\/cvaa228","volume":"117","author":"Nagueh SF","year":"2021","unstructured":"Nagueh SF. Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology. Cardiovasc Res, 2021, 117: 999-1014.","journal-title":"Cardiovasc Res"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3390\/cells11213336","volume":"11","author":"Bhullar SK","year":"2022","unstructured":"Bhullar SK, Dhalla NS. Angiotensin II-induced signal transduction mechanisms for cardiac hypertrophy. Cells, 2022, 11:","journal-title":"Cells"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3724\/abbs.2024130","volume":"56","author":"Yu K","year":"2024","unstructured":"Yu K, Su X, Zhou T, Cai X, Zhang M. EEPD1 attenuates radiation-induced      cardiac hypertrophy and apoptosis by degrading FOXO3A in cardiomyocytes. Acta Biochim Biophys Sin, 2024, 56: 1733-1747.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes14071375","volume":"14","author":"Chakrabortty A","year":"2023","unstructured":"Chakrabortty A, Patton DJ, Smith BF, Agarwal P. miRNAs: potential as biomarkers and therapeutic targets for cancer. Genes, 2023, 14:","journal-title":"Genes"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.119.042474","volume":"141","author":"Gomes CPC","year":"2020","unstructured":"Gomes CPC, Schroen B, Kuster GM, Robinson EL, Ford K, Squire IB, Heymans S. Regulatory RNAs in heart failure. Circulation, 2020, 141: 313-328.","journal-title":"Circulation"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"104108","DOI":"10.1016\/j.ebiom.2022.104108","volume":"81","author":"Li J","year":"2022","unstructured":"Li J, Sha Z, Zhu X, Xu W, Yuan W, Yang T, Jin B. Targeting miR-30d reverses pathological cardiac hypertrophy. eBioMedicine, 2022, 81:","journal-title":"eBioMedicine"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1900023","DOI":"10.1002\/advs.201900023","volume":"6","author":"Zhi Y","year":"2019","unstructured":"Zhi Y, Xu C, Sui D, Du J, Xu F\u2010, Li Y. Effective delivery of hypertrophic mirna inhibitor by cholesterol-containing nanocarriers for preventing pressure overload induced cardiac hypertrophy. Adv Sci, 2019, 6:","journal-title":"Adv Sci"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","volume":"118","author":"Li G","year":"2022","unstructured":"Li G, Shao Y, Guo HC, Zhi Y, Qiao B, Ma K, Du J. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc Res, 2022, 118: 2139-2151.","journal-title":"Cardiovasc Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-016-0341-z","volume":"35","author":"Zhuang Q","year":"2016","unstructured":"Zhuang Q, Zhou T, He C, Zhang S, Qiu Y, Luo B, Zhao R. Protein phosphatase 2A-B55\u03b4 enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b. J Exp Clin Cancer Res, 2016, 35:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3892\/ol.2016.4316","volume":"11","author":"Liu G","year":"2016","unstructured":"Liu G, Li YI, Gao X. Overexpression of microRNA-133b sensitizes non-small cell lung cancer cells to irradiation through the inhibition of glycolysis. Oncol Lett, 2016, 11: 2903-2908.","journal-title":"Oncol Lett"},{"key":"CITATION15","unstructured":"Yang L, Hou J, Cui XH, Suo LN, Lv YW. MiR-133b regulates the expression of CTGF in epithelial-mesenchymal transition of ovarian cancer.  Eur Rev Med Pharmacol Sci  2017, 21: 5602\u20135609."},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"153459","DOI":"10.1016\/j.prp.2021.153459","volume":"223","author":"Hu C","year":"2021","unstructured":"Hu C, Wu J, Wang L, Liu X, Da B, Liu Y, Huang L. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8. Pathol-Res Pract, 2021, 223:","journal-title":"Pathol-Res Pract"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41434-021-00310-5","volume":"29","author":"Liang G","year":"2022","unstructured":"Liang G, Qin Z, Luo Y, Yin J, Shi Z, Wei R, Ma W. Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy. Gene Ther, 2022, 29: 710-719.","journal-title":"Gene Ther"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbrc.2020.07.052","volume":"532","author":"Lai CH","year":"2020","unstructured":"Lai CH, Barik P, Hsieh DJY, Day CH, Ho TJ, Chen RJ, Kuo WW. Inhibition of cell death-inducing p53 target 1 through miR-210-3p overexpression attenuates reactive oxygen species and apoptosis in rat adipose-derived stem cells challenged with angiotensin II. Biochem Biophys Res Commun, 2020, 532: 347-354.","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.celrep.2013.09.020","volume":"5","author":"Namba T","year":"2013","unstructured":"Namba T, Tian F, Chu K, Hwang SY, Yoon KW, Byun S, Hiraki M. CDIP1-BAP31 complex transduces apoptotic signals from endoplasmic reticulum to mitochondria under endoplasmic reticulum stress. Cell Rep, 2013, 5: 331-339.","journal-title":"Cell Rep"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"e15602","DOI":"10.7717\/peerj.15602","volume":"11","author":"Yan G","year":"2023","unstructured":"Yan G, Wang L. Role of ELK1 in regulating colorectal cancer progression: miR-31-5p\/CDIP1 axis in CRC pathogenesis. Peer J, 2023, 11:","journal-title":"Peer J"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/sj.emboj.7601779","volume":"26","author":"Brown L","year":"2007","unstructured":"Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, Khosravi-Far R. CDIP, a novel pro-apoptotic gene, regulates TNF\u03b1-mediated apoptosis in a p53-dependent manner. EMBO J, 2007, 26: 3410-3422.","journal-title":"EMBO J"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","volume":"98","author":"Oldfield CJ","year":"2020","unstructured":"Oldfield CJ, Duhamel TA, Dhalla NS. Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol, 2020, 98: 74-84.","journal-title":"Can J Physiol Pharmacol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13062-022-00334-w","volume":"17","author":"Ji M","year":"2022","unstructured":"Ji M, Liu Y, Zuo Z, Xu C, Lin L, Li Y. Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis. Biol Direct, 2022, 17:","journal-title":"Biol Direct"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/jcmm.14129","volume":"23","author":"Zhu L","year":"2019","unstructured":"Zhu L, Li C, Liu Q, Xu W, Zhou X. Molecular biomarkers in cardiac hypertrophy. J Cell Mol Medi, 2019, 23: 1671-1677.","journal-title":"J Cell Mol Medi"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/brv.12428","volume":"93","author":"Kabekkodu SP","year":"2018","unstructured":"Kabekkodu SP, Shukla V, Varghese VK, D\u2032 Souza J, Chakrabarty S, Satyamoorthy K. Clustered miRNAs and their role in biological functions and diseases. Biol Rev, 2018, 93: 1955-1986.","journal-title":"Biol Rev"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41569-020-00436-w","volume":"17","author":"Robson A","year":"2020","unstructured":"Robson A. Oxidation of miRNAs by ROS leads to cardiac hypertrophy. Nat Rev Cardiol, 2020, 17:","journal-title":"Nat Rev Cardiol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcvm.2019.00170","volume":"6","author":"Liu Y","year":"2019","unstructured":"Liu Y, Afzal J, Vakrou S, Greenland GV, Talbot Jr. CC, Hebl VB, Guan Y. Differences in microRNA-29 and pro-fibrotic gene expression in mouse and human hypertrophic cardiomyopathy. Front Cardiovasc Med, 2019, 6:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"8282","DOI":"10.3892\/mmr.2015.4441","volume":"12","author":"Yin H","year":"2015","unstructured":"Yin H, Zhao L, Zhang S, Zhang Y, Lei S. MicroRNA-1 suppresses cardiac hypertrophy by targeting nuclear factor of activated T cells cytoplasmic 3. Mol Med Rep, 2015, 12: 8282-8288.","journal-title":"Mol Med Rep"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1111\/jcmm.17347","volume":"26","author":"Wang S","year":"2022","unstructured":"Wang S, Dong L, Ma L, Yang S, Zheng Y, Zhang J, Wu C. SQLE facilitates the pancreatic cancer progression via the lncRNA\u2010TTN\u2010AS1\/miR\u2010133b\/SQLE axis. J Cell Mol Medi, 2022, 26: 3636-3647.","journal-title":"J Cell Mol Medi"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41419-018-0715-6","volume":"9","author":"Wang QY","year":"2018","unstructured":"Wang QY, Zhou CX, Zhan MN, Tang J, Wang CL, Ma CN, He M. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. Cell Death Dis, 2018, 9:","journal-title":"Cell Death Dis"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2217\/fon-2020-0420","volume":"17","author":"Ma M","year":"2021","unstructured":"Ma M, Li L, Long F, Xiao H, Lu M, Lin C. MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1. Future Oncol, 2021, 17: 1013-1023.","journal-title":"Future Oncol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.biopha.2018.09.146","volume":"108","author":"Liu B","year":"2018","unstructured":"Liu B, Cheng M, Hu S, Wang S, Wang L, Tu X, Huang C. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy. Biomed Pharmacother, 2018, 108: 1347-1356.","journal-title":"Biomed Pharmacother"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/ijms22031175","volume":"22","author":"Inukai R","year":"2021","unstructured":"Inukai R, Mori K, Kuwata K, Suzuki C, Maki M, Takahara T, Shibata H. The novel ALG-2 target protein CDIP1 promotes cell death by interacting with ESCRT-I and VAPA\/B. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.7150\/thno.27285","volume":"8","author":"Li M","year":"2018","unstructured":"Li M, Ding W, Tariq MA, Chang W, Zhang X, Xu W, Hou L. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p. Theranostics, 2018, 8: 5855-5869.","journal-title":"Theranostics"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/thno.47021","volume":"11","author":"Liao Z","year":"2021","unstructured":"Liao Z, Chen Y, Duan C, Zhu K, Huang R, Zhao H, Hintze M. Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics, 2021, 11: 268-291.","journal-title":"Theranostics"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/1EABF22819B545B9BB6EE6E69CB80377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024181","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/1EABF22819B545B9BB6EE6E69CB80377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T03:08:20Z","timestamp":1757646500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024181","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}